ArticleJournal of orthopaedic research : official publication of the Orthopaedic Research Society2026
MicroRNA-127-3p Inhibits In Vitro Osteogenesis and Dampens Trauma-Induced Heterotopic Ossification In Vivo.
Article in Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
MicroRNAs are small non-coding RNAs that regulate cellular pathways by targeting multiple mRNAs, playing critical roles in skeletal development and homeostasis. Our previous miRNA profiling studies identified higher levels of miR-127-3p in the hypertrophic zone of developing human growth plates while another group found this miRNA to be more highly expressed in murine hindlimb cartilage compared to calvarial bone. Other published work revealed elevated circulating miR-127-3p levels in osteoporotic patients and in long bones of ovariectomized mice. Collectively, these findings suggest a role for miR-127-3p in regulating bone formation. To fill a knowledge gap, we designed a study to determine the function of miR-127-3p in regulating osteogenic differentiation of human bone marrow-derived mesenchymal stromal cells (hBMSCs). While inhibition of miR-127-3p had no effect, mimic overexpression robustly inhibited in vitro osteogenesis. Bulk RNA-sequencing showed a number of cellular pathways affected, including suppression of proliferation-related pathways, which was confirmed by decreased BrdU incorporation. To assess the translational potential of the bone suppressing function of this miRNA, we utilized a pre-clinical mouse model of trauma-induced heterotopic ossification involving Achilles tendon transection. Local delivery of miR-127-3p mimics via peptide-based nanoparticle technology significantly reduced ectopic bone formation at the proximal site of the transected tendon. These studies demonstrate that approaches to overexpress miR-127-3p and induce bone suppressing activity may be of therapeutic value as a means to treat many forms of heterotopic ossification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.